ICU Medical (NASDAQ:ICUI) Hits New 12-Month High – Here’s What Happened

ICU Medical, Inc. (NASDAQ:ICUI)’s stock price hit a new 52-week high on Monday . The company traded as high as $160.62 and last traded at $159.28, with a volume of 256378 shares. The stock had previously closed at $154.97.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Jefferies Financial Group raised shares of ICU Medical to a “strong-buy” rating in a research report on Thursday, May 7th. BTIG Research initiated coverage on ICU Medical in a research note on Monday, June 15th. They issued a “buy” rating and a $170.00 target price for the company. Piper Sandler lowered their target price on ICU Medical from $178.00 to $163.00 and set an “overweight” rating for the company in a report on Friday, April 17th. Zacks Research raised ICU Medical from a “hold” rating to a “strong-buy” rating in a report on Monday, June 29th. Finally, KeyCorp lowered their price objective on ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Three research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, ICU Medical presently has a consensus rating of “Buy” and a consensus target price of $168.40.

ICU Medical Trading Up 2.9%

The firm’s 50-day simple moving average is $133.71 and its 200 day simple moving average is $138.52. The stock has a market capitalization of $3.98 billion, a P/E ratio of 86.18, a PEG ratio of 2.17 and a beta of 0.76. The company has a quick ratio of 1.17, a current ratio of 2.34 and a debt-to-equity ratio of 0.60.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share for the quarter, topping the consensus estimate of $1.78 by $0.19. ICU Medical had a net margin of 2.15% and a return on equity of 7.50%. The firm had revenue of $525.77 million for the quarter, compared to analysts’ expectations of $520.65 million. During the same period in the previous year, the company posted $1.72 EPS. The company’s quarterly revenue was down 12.3% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Equities research analysts anticipate that ICU Medical, Inc. will post 6.5 EPS for the current fiscal year.

Insider Buying and Selling at ICU Medical

In other news, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $124.08, for a total transaction of $303,623.76. Following the sale, the vice president directly owned 19,460 shares of the company’s stock, valued at approximately $2,414,596.80. This trade represents a 11.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director David C. Greenberg sold 2,424 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $122.91, for a total value of $297,933.84. Following the completion of the sale, the director owned 7,960 shares in the company, valued at $978,363.60. This trade represents a 23.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 2.10% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On ICU Medical

Hedge funds have recently added to or reduced their stakes in the business. Hilton Head Capital Partners LLC bought a new stake in ICU Medical during the fourth quarter worth $32,000. Covestor Ltd raised its stake in shares of ICU Medical by 22.1% during the 4th quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier’s stock worth $99,000 after purchasing an additional 126 shares during the period. Strs Ohio boosted its stake in ICU Medical by 60.0% in the fourth quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock valued at $114,000 after acquiring an additional 300 shares during the last quarter. Rockefeller Capital Management L.P. increased its stake in shares of ICU Medical by 21.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock worth $117,000 after purchasing an additional 146 shares during the last quarter. Finally, Kemnay Advisory Services Inc. purchased a new stake in shares of ICU Medical during the 4th quarter worth approximately $120,000. 96.10% of the stock is currently owned by institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.